Kawasaki Disease : An Update

Indian Journal of Pediatrics

Volumn 65, Issue 2, 1998, Pages 231-241

  Singh, Gautam K ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cardinal Glennon Hospital   (United States)

Author keywords

Cardiovascular system; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

CARDIOVASCULAR RISK; CLINICAL FEATURE; CONFERENCE PAPER; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; FIBRINOLYTIC THERAPY; HEART INFARCTION; ISCHEMIC HEART DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; REVASCULARIZATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VASCULITIS;

EID: 0031812730     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02752299     Document Type: Article

References (25)

1. Kawasaki T. Mucocutaneous lymph node syndrome : clinical observation of 50 cases. Jap J Allerg 1967; 16 : 178.
2. Takahashi M. Kawasaki syndrome, In : Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP eds. Moss and Adams' Heart disease in infants, children, and adolescents. 5th ed. Williams and Wilkins, Baltimore 1995; 1390-1399.
3. Nakamura Y, Hirose K, Yanagawa H, et al. Incidence rate of recurrent Kawasaki disease in Japan. Acta Pediatr 1994; 83 : 1061-1064.
4. Leung DYM, Meissner HC, Fulton DR, et al. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki Syndrome. Lancet 1993; 342 : 1385.
5. Abe J, Kotzin BL, Jujok et al. Selective expansion of the T-cells expressing T-cell receptor variable regions V$2 and V$8 in Kawasaki disease. Proc Nati Acada Sci USA 1992; 89 : 4066-4077.
6. Abe J, Kotzin BL, Meissner, et al. Characterization of T-cell repertoire changes in acute Kawasaki disease. J Exp Med 1993; 177 : 791.
7. Fujiwara M, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978; 61 : 100-107.
8. Hijaji ZM, Udelson JE, Snapper M et al. Physiologic significance of chronic coronary aneurysm in patients with Kawasaki disease. J Am Coll Cardiol 1995; 25 : 1425-1427.
9. Paridon S, Galioto F, Vincent J, Tomassoni T, Sullivan N, Bricker J. Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents. J Am Coll Cardiol 1995; 25 : 1420-1424.
10. Suzuki A, Yamagishi M, Kimura K, et al. Functional behaviour and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol 1996; 27 : 291-296.
11. Muzik O, Paridon SM, Singh TP, Morran WR, Dayaniki F, Carli M Di. Quantification of myocardial blood flow and flow reserve in children with history of Kawasaki disease and normal coronary arteries using positron emission tomography. J Am Coll Cardiol 1996; 28 : 752-762.
12. Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis and therapy of Kawasaki disease in children. Circulatin 1993; 87 : 1776-1780.
13. Kawasaki T. Kawasaki disease. Acta Paediatr 1995; 84 : 713-715.
14. Maurice L, Koren G. Atypical Kawasaki disease : analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J 1990; 9 : 122-126.
15. Kato H, Inoue O, Akagi T. Kawasaki disease : cardiac problems and management Pediatr Rev 1988; 9 : 209-217.
16. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324 : 1633-1639.
17. Kato H, Sugmura T, Akagi T, et al. Long-term consequences of Kawasaki disease : a 10-21 year follow-up study of 594 patients. Circulation 1996; 94 : 1379-1385.
18. Dhillon R, Clarkson P, Donald AE, et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996; 94 : 2103-2016.
19. Sugimura T, Kato H, Inoue O, et al. Intravascular ultrasound of coronry arteries in children : assessment of the wall morphology and the lumen after Kawasaki disease. Circulation 1994; 89 : 258-265.
20. Tatara K, Kusakawa S. Long-term prognosis of giant coronary aneurysm in Kawasaki disease : An angiograhic study. J Pediatr 1987; 111 : 705-710.
21. Isiwata S, Fuse K, Nishiyama S, Nakanishi S, Watanabe Y. Adult coronary artery diseae secondary to Kawasaki disease in childhood. Am J Cardiol 1992; 69 : 692-694.
22. Newberger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315 : 341-347.
23. Engle MA, Fatica NS, Bussel JB, O'Loughlin JE, Synder MS, Lesser ML. Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Am J Dis Child 1989; 143 : 1300-1304.
24. Dajani AS, Tauber K, Takahashi M, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994; 89 : 916-922.
25. Kitamura S, Kameda Y, Seki T, et al. Long-term outcome of mycoardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg 1994; 107 : 663-673.